Marc Brown

Articles by Marc Brown

Not to be sniffed at

December 1st 2005

Pharmaceutical Technology Europe

The attraction of nasal administered therapeutic agents is obvious, including faster onset of action, increased compliance and avoiding degradation during first pass metabolism.

Latest Updated Articles

Not to be sniffed at
December 1st 2005

Marc Brown

Articles by Marc Brown

Not to be sniffed at

Latest Updated Articles

Trending on Pharmaceutical Technology

Why Big Pharma Is Betting Billions on Protein Degraders for Cancer

Delaware Governor Meyer on Drug Pricing, Reshoring, and National Security

PharmTech Weekly Roundup—June 5, 2026

Tom Sellig on CDMO Innovation and US Manufacturing Growth

Renewing Prosaic Generics for Cancer Treatment